|
Volumn 41, Issue 2, 2009, Pages 674-675
|
De Novo Malignancy After Solid Organ Transplantation in Children
g
ENV de Nantes
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN;
DACLIZUMAB;
LYMPHOCYTE ANTIBODY;
MONOCLONAL ANTIBODY CD3;
RITUXIMAB;
TACROLIMUS;
ADENOCARCINOMA;
ADOLESCENT;
ARTICLE;
BURKITT LYMPHOMA;
CANCER CHEMOTHERAPY;
CHILD;
GRAFT REJECTION;
HEALTH SURVEY;
HEART TRANSPLANTATION;
HEPATOBLASTOMA;
HODGKIN DISEASE;
HUMAN;
INTESTINE TRANSPLANTATION;
KAPOSI SARCOMA;
KIDNEY CARCINOMA;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
LUNG SARCOMA;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
NEOPLASM;
NONHODGKIN LYMPHOMA;
ORGAN TRANSPLANTATION;
PANCREAS TUMOR;
POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE;
PRESCHOOL CHILD;
PREVALENCE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RETROSPECTIVE STUDY;
SCHOOL CHILD;
SKIN CANCER;
SOLID TUMOR;
CHILD;
HUMANS;
INCIDENCE;
INTESTINE, SMALL;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISORDERS;
NEOPLASMS;
ORGAN TRANSPLANTATION;
PREVALENCE;
QUESTIONNAIRES;
RETROSPECTIVE STUDIES;
|
EID: 62849098426
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.12.020 Document Type: Article |
Times cited : (42)
|
References (5)
|